NEWS
SUBSCRIBER SEARCH (Requires Login)
  NEW DRUGS
  MARKETED DRUGS
  COMPANY
  TARGETS IN ONCOLOGY
  NEWS SUMMARIES
  COMBINATION TRIALS

Latest Updates

January 2010 Company Updates and Additions

  • 4-Antibody
  • A&G Pharmaceutical
  • Abbott Diagnostics
  • Abeome
  • Abraxis BioScience
  • Acceleron Pharma
  • Access Pharmaceuticals
  • Acetylon Pharmaceuticals
  • ACT Biotech
  • AdnaGen
  • Adolor
  • Advaxis
  • ADVENTRX Pharmaceuticals
  • Afferent Pharmaceuticals
  • Applied Genomics (AGI)
  • Apthera
  • Ark Therapeutics
  • Arrayit
  • Arrowhead Research
  • Azaya Therapeutics
  • BIND Biosciences
  • Biocept
  • BioCurex
  • Biogen Idec
  • BioNumerik Pharmaceuticals
  • biosyn
  • BioVex
  • Calibrant Biosystems
  • Caris Diagnostics (Caris Dx)
  • Celgene
  • Cell Therapeutics (CTI)
  • Cempra Pharmaceuticals
  • China Aoxing Pharmaceutical Company
  • Clavis Pharma
  • CombinatoRx
  • Compugen
  • Cornerstone Pharmaceuticals
  • Correlogic Systems
  • CovX Research
  • Critical Outcome Technologies (COTI)
  • Curis
  • CytRx
  • Debiopharm Group
  • deCODE genetics
  • Depomed (DMI)
  • Diffusion Pharmaceuticals
  • Dynavax Technologies
  • Ensemble Discovery
  • EpiCept
  • ERYtech Pharma
  • Evolva Holding
  • Fabrus
  • Fate Therapeutics
  • Flexion Therapeutics
  • Fujirebio Diagnostics (FDI)
  • GenSpera
  • GlobeImmune
  • GTC Biotherapeutics (GTC)
  • HealthLinx
  • Ikonisys
  • Illumina
  • ImClone Systems
  • Imed
  • Immune Design (IDC)

 

  • INC Research
  • InDex Pharmaceuticals
  • Inovio Biomedical
  • Intellikine
  • Inverness Medical Innovations
  • IRX Therapeutics
  • IsoRay Medical
  • IVAX Diagnostics
  • KaloBios Pharmaceuticals
  • Ligand Pharmaceuticals
  • MacroGenics
  • MDRNA
  • Mebiopharm
  • Med BioGene (MBI)
  • Meda
  • Medifocus
  • Mirna Therapeutics
  • Mologen
  • NeoDynamics
  • NeoGenomics
  • NeoPharm
  • Neoprobe
  • NuRx Pharmaceuticals
  • Ohr Pharmaceutical
  • On-Q-ity (OnQity)
  • OncImmune
  • OncoMed Pharmaceuticals
  • Oncopeptides
  • ParagonDx
  • Pathway Therapeutics
  • Patrys
  • Pieris
  • Plexxikon
  • Predictive Biosciences
  • Priaxon
  • Prometheus Laboratories
  • Provenance Biopharmaceuticals
  • Regulus Therapeutics
  • ribOvax biotech
  • Roche
  • Rosetta Genomics
  • Sanguine
  • Sirtex Medical
  • Strategic Diagnostics (SDI)
  • Surface Logix
  • Symphogen
  • Syndax Pharmaceuticals
  • Synta Pharmaceuticals
  • T2 Biosystems
  • Taris Biomedical
  • TetraLogic Pharmaceuticals
  • Thallion Pharmaceuticals
  • Traversa Therapeutics
  • Trillium Therapeutics (TTI)
  • Trubion Pharmaceuticals
  • Veridex
  • Vermillion
  • Viamet Pharmaceuticals
  • Vical
  • ViroMed
  • Xenomics
  • Xigen
  • Zila

 

  

Home   |    Freelance Opportunities   |   New Medicine   |   Site Map   |  Order/Inquiry   
SUBSCRIBER SEARCH:   NEW DRUG   |   MARKETED DRUG   |   COMPANY   |   TARGETS IN ONCOLOGY  

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM